Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium

References

• Fisher JF, Newman CL, Sobel JD. Yeast in the urine: solutions for a budding problem. Clin Infect Dis 1995; 20: 183–189.
   Google Scholar
• Knoke M, Schulz K, Bemhardt H. Dynamics of Candida isolations from humans in 1992-1995 in Greifswald, Germany. Mycoses 1997; 40: 105–110.
   Google Scholar
• Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multi-center surveillance study of funguria in hospitalized patients. Clin Infect Dis 2000; 30: 14–18.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Kauffman CA, McKinsey D, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. Clin Infect Dis 2000; 30: 19–24.
   PubMed Web of Science ®Google Scholar
• Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host. Am J Med 1981; 71: 363–370.
   Google Scholar
• Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospi-talized patients: frequency, characteristics and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11: 379–390.
   PubMedGoogle Scholar
• Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States 1980–1989. National Nosocomial Surveillance System. Am J Med 1991; 91 (Suppl. 3B): 865–895.
   Google Scholar
• Fraser VJ, Jones M, Dunkel J, Stofer S, Medoff G, Dunagan C. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414–421.
   PubMed Web of Science ®Google Scholar
• Levy I, Rubin LG, Vasistha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998; 26: 1086–1088.
   Google Scholar
• Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115–125.
   PubMed Web of Science ®Google Scholar
• Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–1277.
   PubMed Web of Science ®Google Scholar
• Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994; 331: 1325–1330.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Peacock JF, Morris AJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617–623.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999; 33: 217–222.
   PubMed Web of Science ®Google Scholar
• Edmonds MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States Hospitals: A three year analysis. Clin Infect Dis 1999; 29: 239–244.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Rhune-Chalberg J, Barry AL, Rex JH. Strain variation and antifungal susceptibility among bloodstream iso-lates of Candida species from 21 different medical institutions. Clin Infect Dis 1995; 21: 1507–1509.
   PubMed Web of Science ®Google Scholar
• Nucci M, Silveira MI, Spector N, et al. Risk factors for death among cancer patients with fungemia. Clin Infect Dis 1998; 27: 107–111.
   PubMed Web of Science ®Google Scholar
• Powderly WG. Resistant candidiasis. AIDS Res Hum Retro-viruses 1994; 10: 925–929.
   PubMed Web of Science ®Google Scholar
• Pelz R, Lipsett PA, Swoboda S, et al. Do surveillance cultures predict fungal infection in critically ill patients? 36th Annual Meeting of the Infectious Diseases Society of America. Denver, November 12–15,1998. Arlington, VA: IDSA, 1998: Abstract 103.
   Google Scholar
• Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751–758.
   Google Scholar
• Yoon SA, Vazquez JA, Steffan PE, Sobel JD, Akins RA. High-frequency, in vitro reversible switching of Candida lusita-niae clinical isolates from amphotericin B susceptibility to resis-tance. Antimicrob Agents Chemother 1999; 43: 836–845.
   Google Scholar
• Edwards Jr JE, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the manage-ment and prevention of severe candidal infections. Clin Infect Dis 1997; 25: 43–59.
   PubMed Web of Science ®Google Scholar
• Lecciones JA, Lee JW, Navarro FP, et al. Vascular catheter-as-sociated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992; 14: 875–883.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Peacock Jr JE, Tanner DC, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multi-center, prospective, observational study. Arch Intern Med 1995; 155: 2429–2435.
   Google Scholar
• Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter exchanges and the duration of candidemia. Clin Infect Dis 1995; 21: 994–996.
   PubMed Web of Science ®Google Scholar
• Anaissie EJ, Rex JH, Uzun 6, Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998; 104: 238–245.
   Google Scholar
• Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized patients. Chest 1991; 100: 1619–1636.
   Google Scholar
• Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the anti-leukemic regimen. Clin Infect Dis 1995; 21: 361–369.
   PubMed Web of Science ®Google Scholar
• Bow EJ, Loewen R, Cheang MS, et al. Cytotoxic therapy-in-duced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia ther-apy in adults. J Gun Oncol 1997; 15: 2254–2261.
   Google Scholar
• Akler ME, Vellend H, McNeely DM, Walmsley SL, Gold WL. Use of fluconazole in the treatment of candidal endophthalmi-tis. Clin Infect Dis 1995; 20: 657–664.
   PubMed Web of Science ®Google Scholar
• Edwards Jr JE, Foos RY, Montgomery JZ, Guze LB. Ocular manifestations of Candida septicemia; review of seventy six cases of hematogenous Candida endophthalmitis. Medicine 1974; 53: 47–75.
   PubMed Web of Science ®Google Scholar
• Martinez-Vasquez C, Fernandez-Ulloa J, Bordon J, et al. Can-dida albicans endophthalmitis in brown heroin addicts: Re-sponse to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis 1998; 27: 1130–1133.
   PubMed Web of Science ®Google Scholar
• Garbino J, Lew D, Romand J-A, Auckenthaler R, Suter P, Pittet D. Fluconazole prevents severe Candida spp. infections in high-risk critically ill patients. A randomized, double-blind, placebo-controlled study. 37th Interscience Conference on An-timicrobial Agents and Chemotherapy, San Francisco, Septem-ber 13–16, 1997. Arlington, VA: IDSA, 1997: Abstract LM–23b.
   Google Scholar
• Hadley S, Samore MH, Lewis WD, et al. Major infectious complications after orthotopic liver transplantation and com-parison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 1995; 59: 851–859.
   PubMed Web of Science ®Google Scholar
• Martino P, Girmenia C, Micozzi A, et al. Prospective study of Candida colonization, use of empiric amphotericin B and devel-opment of invasive mycosis in neutropenic patients. Eur J Clin Microbiol Infect Dis 1994; 13: 797–804.
   PubMed Web of Science ®Google Scholar
• Girmenia C, Martino P, De Bemardis F, et al. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differ-ential pathogenicity of the causative strains. Clin Infect Dis 1996; 23: 506–514.
   PubMed Web of Science ®Google Scholar
• Wingard JR, Merz WG, Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 1979; 91: 539–543.
   Google Scholar
• De Bemardis F, Girmenia C, Boccanera M, et al. Use of a monoclonal antibody in a dot immunobinding assay for the detection of a circulating mannoprotein on Candida spp in neutropenic patients with invasive candidiasis. J Clin Microbiol 1993; 31: 3142–3146.
   PubMed Web of Science ®Google Scholar
• Girmenia C, Martino P, De Bemardis F, Cassone A. Assess-ment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease. J Gun Microbiol 1997; 35: 903–906.
   Web of Science ®Google Scholar
• Pestalozzi BC, Krestin GP, Schanz U, Jacky E, Gmur J. Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia. Blood 1997; 90: 3858–3864.
   Google Scholar